The biggest lesson from comparing GLP-1 providers is that the cheap-looking option is not always the inexpensive one. The real comparison starts with pharmacy transparency, follow-up, refill timing, and the full monthly number.
Here is what I actually looked at when sorting through the options.
Quick Comparison: Major GLP-1 Telehealth Providers
| Provider | Starting Price (sema) | Starting Price (tirz) | Compounded? | Insurance? | Ships All 50 States? | Notable Edge |
| Mochi Health | ~$99/mo | ~$199/mo | Yes | No | Yes | Obesity-medicine MDs |
| FormBlends | ~$299/vial | ~$349/vial | Yes | No | 47 states | Published HPLC/mass spec purity data |
| Hims & Hers | ~$249/mo (oral) | ~$399/mo | No (post-Mar 2026) | Yes (branded) | Yes | Brand-name access, big support team |
| Ro Body | Meds separate | Meds separate | No | Yes (branded) | Yes | Prior-auth help, $39 first month |
| Henry Meds | ~$179-249/mo | Varies | Yes | No | Yes | 24-72h shipping, low friction |
| PlushCare | Meds separate | Meds separate | No | Yes | Yes | $19.99/mo membership, same-day visits |
| Found | ~$99/mo + meds | ~$99/mo + meds | Varies | Varies | Yes | Coaching included |
| Form Health | ~$299/mo + meds | ~$299/mo + meds | No | Varies | Yes | MD plus registered dietitian |
| Eden | ~$149/mo | Varies | Yes | No | Most states | Low cash-pay entry |
| Sesame | ~$59/mo (annual) | Meds separate | No | No | Yes | Transparent a-la-carte pricing |
1. Confirm Whether Compounded Meds Are Still Legal From That Provider
This is the first filter. After the March 2026 Novo settlement and the wave of FDA warning letters, not every company that started on compounded semaglutide still offers it legally. Hims & Hers exited compounded GLP-1 entirely after the settlement. Others quietly pivoted. Ask explicitly: is this a 503A pharmacy, a 503B, or a brand-name prescription?
2. Mochi Health: Best for Clinical Depth on a Budget
Mochi stands out because their clinicians carry board certification in obesity medicine, not just general practice. That is a real difference in how they interpret your labs and titrate your dose. Compounded sema runs around $99 a month. Compounded tirzepatide is around $199. The monitoring is heavier than most cash-pay competitors, which I consider a feature, not overhead.
3. FormBlends: Best If You Want Published Purity Testing
Most GLP-1 telehealth brands tell you their pharmacy is “reputable.” FormBlends actually publishes per-product purity data: HPLC purity percentages, mass spectrometry identity confirmation, and endotoxin/sterility results. That is unusual and genuinely useful for anyone who wants to verify what they are injecting, not just trust a press release.
Pricing runs higher than many competitors, around $299 for semaglutide and $349 for tirzepatide per vial. Ships to 47 states, not all 50. They also carry a broader peptide catalog covering recovery and cognitive peptides under the same clinician model, which most GLP-1-only platforms skip entirely. Worth it if verified purity or a wider peptide menu matters to you. Not the cheapest path.
4. Hims & Hers: Best for Brand-Name Access With Insurance
Injectable Wegovy runs about $299 a month through Hims & Hers, Zepbound around $399, oral sema around $249. With insurance and a manufacturer savings card that can drop to nearly nothing. They have the infrastructure for that process. The compounded era is over for them, so if you wanted that route, look elsewhere.
5. Ro Body: Best Prior-Authorization Support
Ro’s prior-auth team does the insurance paperwork with you, which is worth real money if branded Wegovy or Zepbound is what you’re after. First month is $39, then $74 to $149, with medications billed separately. The real cost depends almost entirely on what your insurance covers.
6. Henry Meds: Fastest Shipping of the Compounded Options
Henry ships in 24 to 72 hours, which beats most compounding-based telehealth by days. Starting price is roughly $179 to $249 for the first month. Lighter on clinical monitoring than Mochi. Fine if your primary care doctor is already involved in your care and you just need the medication.
7. PlushCare: Best If You Already Have Insurance and Want Same-Day Access
The membership fee is $19.99 a month. They write for branded medications, take most major insurance plans, and can often get you in with a clinician the same day. Not a weight-loss-only platform, which means less specialty focus but more scheduling flexibility.
8. Form Health: Best for High-Touch Medical Supervision
Form Health pairs you with a physician and a registered dietitian. That combination is rare in telehealth. The platform fee runs about $299 a month before medications and labs. Expensive. But for someone with a complicated history or prior weight-loss failures, having a dietitian who actually reviews your food logs alongside an MD is a different category of care.
9. Sesame: Best for Pure Price Transparency
Sesame prices everything a-la-carte, starting around $59 a month on an annual plan. Medications are separate. There are no bundles hiding costs inside a membership you don’t fully understand. Good for people who want to see every line item before committing.
10. Verify the Pharmacy, Not Just the Brand
Whatever provider you pick, find out exactly where your medication is compounded. A named 503A pharmacy with USP-797 compliance and lot tracking is meaningfully different from a vague “licensed compounding partner.” HealthRX, for example, dispenses through Manifest Pharmacy in Greer, South Carolina, a 503A facility with lot-tracked production and LegitScript certification, which is the kind of specific answer worth looking for from any provider you’re considering.
Eli Lilly’s published cash price for oral orforglipron via LillyDirect, announced in April 2026, came in at roughly $149 a month. That makes it a real option if you want a branded oral GLP-1 without the compounding question altogether.
Common Questions
Is compounded semaglutide still available from any of these providers in 2026?
Yes, but fewer than before. After the March 2026 Novo Nordisk settlement and FDA warning letters to more than 30 compounding firms, several major platforms exited the space entirely. Mochi Health, Henry Meds, Eden, and FormBlends still offered compounded semaglutide as of early 2026. Confirm current availability directly before enrolling, because the situation keeps moving.
What actually separates Mochi Health from a cheaper option like Eden or Henry Meds?
Clinician credentials. Mochi’s providers hold board certification in obesity medicine, which shapes how they handle dose titration, interpret labs, and manage side effects. Eden and Henry Meds are lower-friction and cheaper entry points, but neither emphasizes specialty credentials the same way. If you have a complex metabolic history, that difference matters.
How do I know if a compounding pharmacy behind one of these platforms is legitimate?
Ask for the pharmacy’s name, state license number, 503A or 503B designation, and whether it holds LegitScript certification. USP-797 compliance and lot-tracked production are worth confirming too. A provider that cannot or will not give you a named pharmacy with verifiable credentials is a red flag, regardless of how polished the website looks.
Does FormBlends’ published purity data actually mean the product is safer than competitors?
It means you can verify the claim rather than take it on faith. HPLC purity percentages and mass spectrometry identity confirmation tell you the active ingredient is present and correctly identified. Most competitors offer no equivalent documentation. That is a meaningful transparency difference, though it does not guarantee clinical outcomes, and the higher per-vial price reflects the added testing overhead.
If I have insurance, which of these platforms gives me the best shot at paying close to nothing for Wegovy or Zepbound?
Ro Body and Hims & Hers both support branded GLP-1 prescriptions with active prior-authorization help and manufacturer savings card guidance. Ro’s prior-auth team is a particular strength here. PlushCare also accepts major insurance and can get you in same-day, though it is less specialized in the weight-loss prior-auth workflow. Your actual out-of-pocket cost depends on your specific plan’s formulary.
*Prices shown are publicly listed cash-pay rates as of early 2026 and can change. Always confirm current pricing and availability directly with each provider before enrolling.*
Sources
- FDA: Warning letters to outsourcing and compounding facilities, early 2026 (FDA.gov press releases)
- Novo Nordisk / Hims & Hers settlement coverage, March 9 2026 (Reuters, STAT News)
- SURMOUNT-1 trial: tirzepatide weight loss data, NEJM 2022
- STEP 1 trial: semaglutide weight loss data, NEJM 2021
- Eli Lilly orforglipron cash-pay pricing disclosure, April 2026 (Eli Lilly press release)
- LegitScript certification database (LegitScript.com)
